Aimed Alliance has released new recommendations for reforming the federal 340B Drug Pricing Program and advancing state-based alternatives to strengthen…
On August 14, Aimed Alliance submitted a comment to the Senate Finance Committee’s Request for Information on Commonsense Policy Options…
A new Yale University study raises questions about how the Trump Administration’s proposed Medicare international reference pricing (IRP) models, GLOBE…
On August 27, 2026, Aimed Alliance submitted feedback on Senator Cassidy’s 340B Drug Pricing Integrity and Affordability for Patients Act…
Aimed Alliance released three new patient-centered resources as part of its Patients & PDABs: Ensuring a Voice in the Process…
On August 13, 2026, Aimed Alliance submitted comments to CMS regarding its proposed rule to codify the Medicare Drug Price…
Prior to the Board’s July meeting to conduct cost affordability reviews for Farxiga and Jardiance, Aimed Alliance submitted a letter…
On July 27, 2026, Aimed Alliance sent a letter to the Maryland Prescription Drug Affordability Board urging it to not…
The U.S. Trade Office has announced it is opening an investigation into Germany over its spending on prescription drugs, with…
On June 24, Aimed Alliance sent a letter to the Colorado Prescription Drug Affordability Board urging it not to establish…